6 Results for "

MLL1-WDR5 interaction

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "MLL1-WDR5 interaction" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-12220
CAS No.: 1417329-24-8
Purity:  99.39%
Synonyms: HMTase Inhibitor IX
MM-102 (HMTase Inhibitor IX) is a cell-permeable and tightly binding inhibitor of MLL1-WDR5 interaction (IC50=2.4 nM). MM-102 can specifically inhibit the growth and induce apoptosis of leukemia cells containing MLL1 fusion protein, and reduce renal fibrosis and inflammation in mice with ischemia-reperfusion injury. In addition, MM-102 also acts as an H3K4 histone methyltransferase inhibitor to improve the development of porcine somatic cell nuclear transfer (SCNT) embryos .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19554A
CAS No.: 1442106-11-7
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

MM-401 (TFA) is a MLL1 H3K4 methyltransferase inhibitor. MM-401 inhibits MLL1 activity (IC50 = 0.32 μM) by blocking MLL1-WDR5 interaction. MM-401 can induce cell cycle arrest, apoptosis and differentiation. MM-401 can be used for the research of MLL leukemia .
loading...
    loading...
Cat. No.: HY-175802
CAS No.: 2982574-79-6
Synonyms: HYBI-084
Target:  

WDR5 Potassium Channel

Research Areas:  

Inflammation/Immunology Cancer

HBI-2375 (HYBI-084) is a brain-penetrant WDR5 inhibitor with an IC50 of 4.48 nM. HBI-2375 binds to the WINR5 and disrupts MLL1-WDR5 protein-protein interactions. HBI-2375 inhibits cancer cells proliferation and shows anti-tumor activity in AML mouse models, and increases tumor CD8 + cytotoxic T lymphocyte infiltration. HBI-2375 inhibits hERG with an IC50 of 17 µM .
loading...
    loading...
Cat. No.: HY-19554
CAS No.: 1442106-10-6
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

MM-401 is a MLL1 H3K4 methyltransferase inhibitor. MM-401 inhibits MLL1 activity (IC50 = 0.32 μM) by blocking MLL1-WDR5 interaction. MM-401 can induce cell cycle arrest, apoptosis and differentiation. MM-401 can be used for the research of MLL leukemia .
loading...
    loading...
Cat. No.: HY-132233A
Purity:  98.52%
Research Areas:  

Cancer

DDO-2093 dihydrochloride is a potent MLL1-WDR5 protein-protein interaction inhibitor (IC50=8.6 nM; Kd=11.6 nM) with antitumor activity. DDO-2093 dihydrochloride selectively inhibits the catalytic activity of MLL complex .
loading...
    loading...
Cat. No.: HY-132233
CAS No.: 2250024-74-7
Target:  

WDR5

Research Areas:  

Cancer

DDO-2093 is a potent MLL1-WDR5 protein-protein interaction inhibitor (IC50=8.6 nM; Kd=11.6 nM) with antitumor activity. DDO-2093 selectively inhibits the catalytic activity of MLL complex .
loading...
    loading...